Serum Follistatin as Short-Term Prognostic Markers for Patients with Chronic Liver Disease
Chronic Liver Disease (CLD) is caused by several agents and leads to mortality through various mechanisms. Several prognostic factors have been discussed for CLD. Follistatin (FST) is a potential marker for liver function, muscle function, and metabolism. We evaluated whether FST correlated with prognosis and clinical factors